MedPath
HSA Approval

FERASIRO FILM COATED TABLET 360MG

SIN17087P

FERASIRO FILM COATED TABLET 360MG

FERASIRO FILM COATED TABLET 360MG

September 19, 2024

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantGOLDPLUS UNIVERSAL PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

V03AC03

Manufacturer Information

GOLDPLUS UNIVERSAL PTE LTD

MSN Laboratories Private Limited

Active Ingredients

Deferasirox

360.00mg

Deferasirox

Documents

Package Inserts

Ferasiro Film Coated Tablet PI.pdf

Approved: September 19, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.